AI-generated summary
The authors report on transgenic mouse models of dementia, examining whether one month of near infrared light treatment affected brain pathology in the cerebellum. In APP/PS1 mice, they report reduced deposition of beta-amyloid, and in K3 mice they report reduced tau-related pathology, oxidative stress damage and loss of cytochrome oxidase expression. The study uses animal models, and the abstract does not report sample sizes or wavelengths.
- Who or what was studied
- Transgenic mouse models: APP/PS1 and K3 tau strains
- Limits stated in the abstract
- The study is in transgenic mice, and the abstract does not report sample sizes, control details or wavelengths, and it does not show clinical effects in humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dementia, Near-infrared, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.